BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Genetown

  Harbour BioMed Secures $85 Million in Financing Round to Support Clinical-Stage Compounds

  The latest financing round, which the company is calling a B-plus round, will drive the company’s clinical programs toward key milestones.

  March 12, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  BioSpace Movers & Shakers, March 13

  Companies strengthen their leadership teams and executive boards with this week’s Movers & Shakers.

  March 12, 2020

   · 

  5 min read

   · 

  Alex Keown
• 

  Drug Development

  AstraZeneca and Merck’s Combo Therapy Flunks Late-Stage Ovarian Cancer Trial

  The primary endpoint was a statistically significant improvement in progression-free survival for the combination versus platinum-based chemotherapy.

  March 12, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Thermo Fisher & J&J Team Up to Develop Lung Cancer Companion Diagnostic

  No financial terms were disclosed.

  March 12, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Genetown

  With an Eye on the Clinic, Atlas-Backed Kymera Secures $102 Million

  Kymera Therapeutics closed a $102 million Series C funding round to continue advancing the company’s lead targeted protein degradation asset for oncology and immunology.

  March 12, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  CDC Specs Limit Labs’ Ability to Test for COVID-19

  More flexible versions of the COVID-19 diagnostic tests are being developed but, currently, are only available for research.

  March 12, 2020

   · 

  3 min read

   · 

  Gail Dutton
• 

  Biotech Bay

  Nurix Closes $120 Million Financing to Support Protein Degradation Program

  It expects to use the funds to advance its wholly-owned development candidates into the clinic.

  March 12, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Deals

  Flagship Pioneering Merges Sister Companies to Form Repertoire Immune Medicines

  The new company is focused on tapping into the powers of the immune system to address numerous diseases.

  March 12, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  BioForest

  Research Roundup: Higher Coronavirus Infections Than Estimated and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  March 12, 2020

   · 

  5 min read

   · 

  Mark Terry
• 

  Report Released on New Nanopore Technology for the Diagnosis of Sepsis

  This new technique uses real-time, next-generation sequencing that uses tiny amounts of microbial cell-free DNA from sepsis patients’ plasma.

  March 12, 2020

   · 

  2 min read

   · 

  Michelle Brugioni